A probiotic-based regenerative therapy for reversing diabetes:  Probiotic VSL#3-based regenerative therapy for reversing diabetes: Probiotic VSL#3 increases the expression of Sox17, Sox2, Pdx-1, and Ngn3, decreases mTOR expression, promotes regeneration of insulin-producing ß cells, increases insulin secretion, promotes glucose homeostasis and reverses T1D and T2D via down-regulation of its target gene, 16/December/2018, 12.13 am

Erythropoietin(EPO)/Hematopoietin-based therapy for Diabetes Mellitus: Erythropoietin(EPO) augments the expression of FGF19 and FGF1,  attenuates hepatic glucose production, decreases hepatic acetyl CoA content, brings down the levels of plasma ACTH, and corticosterone, augments insulin sensitivity, promotes weight loss and alleviates TIDM, via upregulation of its target gene, 15/December/2018, 12.18 am
December 14, 2018
A probiotic way to protect your heart from cardiac diseases and cardiac ageing: Probiotic Weissella koreensis OKI-6 inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction, via up-regulation of PNUTS, 16/December/2018, 11.01 pm
December 16, 2018
Show all

Introduction: What they say

A study from the Longevity Institute, School of Gerontology, Department of Biological Sciences, University of Southern California, 3715 McClintock Avenue, Los Angeles, California, USA; and Koch Institute at MIT, 500 Main Street, Cambridge, USA shows that “Fasting-Mimicking Diet Promotes Ngn3-Driven ß-Cell Regeneration to Reverse Diabetes.” This research paper was published, in the 23 February 2017 issue of the journal “Cell” [One of the best research journals in Biology with an I.F of 28 plus], by  Prof. and Director of Longevity institute Valter Longo, Cheng CW and others.


What we say:

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: A probiotic-based regenerative therapy for reversing diabetes:  Probiotic VSL#3-based regenerative therapy for reversing diabetes: Probiotic VSL#3 increases the expression of Sox17, Sox2, Pdx-1, and Ngn3, decreases mTOR expression, promotes regeneration of insulin-producing ß cells, increases insulin secretion, promotes glucose homeostasis and reverses T1D and T2D via down-regulation of its target gene

 

[easy_payment currency=”USD”]


From the significance of the study to Public health relevance:

Given that: (1) more than 387 million people worldwide are affected by Diabetes mellitus (DM); (2) Diabetes is going to be one of the top 10 causes of death by 2030; (3) the life-long painful injection/drug treatment is required to treat DM; (3) the global economic cost spent for diabetes treatment in 2014 was little more than 600 billion US dollars, there is an urgent need to find: (i) a way to induce regeneration of adult ß-cells that were lost in DM; (ii) a cheaper alternative to the existing expensive weight-loss drugs; (iii) a side-effect-free natural product-based drug; and (iv) a way to cure, not just treat, diabetes.


What is known?

It has recently been shown that fasting mimicking diet (FMD):(1) increases the expression of Sox17, Pdx-1 (Pancreatic And Duodenal Homeobox 1), & Ngn3 (Neurogenin-3) sequentially; (2) promotes regeneration of insulin-producing ß cells; (3) decreases PKA (Protein Kinase A) and mTOR activity; (4) increases reprogramming proteins Sox2 and Ngn3 expression; (5) increases insulin secretion; and (6) promotes glucose homeostasis, suggesting that FMD: (i) promotes reprogramming of pancreatic cells to restore insulin secretion in islets; and (ii) can reverse both T1D and T2D.


From research findings to Therapeutic opportunity:

This study suggests, for the first time, a Probiotic VSL#3-based regenerative therapy for T1D and TIID.  Probiotic VSL#3 has been shown to decrease blood sugar and protect against autoimmune diabetes. However, the mechanism of action remains elusive.

 Probiotic VSL#3, by increasing the expression of its target genes, it may increase the expression of Sox17, Ngn3, Sox2, Pdx-1, NKX6.1, Pax6, INS etc. (Fig. 1). Thereby,  it may: (1) decrease the expression of mTOR;  (2) increase generation of insulin-producing ß cells; (3) increase insulin secretion; and (4) promote glucose homeostasis, suggesting that Probiotic VSL#3–may replace the need for FMD (Fast mimicking diet) or function as an effective alternative to FMD–may find their use in clinic in attenuating and/or reversing both T1D and T2D, as they turn on most of the reprogramming/insulin-producing genes turned by the FMD (Fig.1).

Figure 1. Mechanistic insights into how Probiotic VSL#3, by turning on the expression of Ngn3, NKX6.1, Pax6, and INS and others anti-diabetic genes, may promote reprogramming of pancreatic cells to restore insulin secretion in islets; and reverse both T1D and T2D.

Figure 2. Probiotic VSL#3-based therapy for Diabetes.

Thus, Probiotic VSL#3 or its equivalents, either alone or in combination with other compounds, may be used to treat and cure T1D and T2D (Fig.2). Together, this study suggests, for the first time, that Probiotic VSL#3-based therapy may be used to treat and/or cure T1D and T2D.

[easy_payment currency=”USD”]


Details of the research findings:

Idea Proposed/Formulated (with experimental evidence) by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic information: How does Probiotic VSL#3 increase the expression of Sox17, Sox2, Pdx-1, and Ngn3?

Amount: $750#

# Research cooperation

For purchase and payment details, you may reach us at info@genomediscovery.org


References:

Web: http://genomediscovery.org or http://newbioideas.com

Citation: Boominathan, L., A probiotic-based regenerative therapy for reversing diabetes:  Probiotic VSL#3-based regenerative therapy for reversing diabetes: Probiotic VSL#3 increases the expression of Sox17, Sox2, Pdx-1, and Ngn3, decreases mTOR expression, promotes regeneration of insulin-producing ß cells, increases insulin secretion, promotes glucose homeostasis and reverses T1D and T2D via down-regulation of its target gene, 16/December/2018, 12.13 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite us, drop us a line at info@genomediscovery.org

Comments are closed.